As we all know, the growth of any type of mammalian cell in vitro needs extracellular matrices, growth media, and environmental factors, as well as iPSC. However, the iPSC culture has several specific factors need took into consideration, which may influence the quality, robustness, and utility of a variety of iPSC culture methods.
With the advanced technology platform and experienced scientists, Creative Biolabs has employed TALEN services to generate innovative and effective cell therapy for our customers. Aided by our TALEN platform, you can revolutionize your particular project by enabling any site-specific genome editing without introducing foreign DNA.
Creative Biolabs is dedicated to providing several viable and cost-effective methods for pluripotent stem cell (iPSC) reprogramming. We employ advanced iPSC reprogramming factor delivery strategy by virus, iPSC reprogramming factor delivery by episomal vectors, as well as other iPSC reprogramming methods (mRNA, protein) to help you obtain the desired iPSC.
Alzheimer's disease (AD) is one of the most concerning neurodegenerative diseases. As a global leading CRO company focusing on neuroscience research, Creative Biolabs has an advanced technology platform providing various kinds of AD in vitro disease model services to help accelerate AD studies.
Creative Biolabs is the specialist provider of an AD biomarker assay. We have a professional team of scientists to provide a comprehensive range of rapid AD Biomarker assays through standard experimental procedures to meet the different needs of AD research.
Creative Biolabs is always the leader in 3D neural spheroids culture technology services and offers a variety of technologies to help you grow 3D neural spheroids quickly and efficiently. In addition, we also provide functional tests and a one-stop service for your research and development to bring more physiological relevance.
Recombinant monoclonal antibody to BAFF. Tabalumab (LY 2127399) is an anti-B-cell activating factor (BAFF) human monoclonal antibody designed for the treatment of autoimmune diseases and B cell malignancies.
CD79B (CD79b Molecule) is a Protein Coding gene. Diseases associated with CD79B include Agammaglobulinemia 6, Autosomal Recessive and Agammaglobulinemia, Non-Bruton Type. Among its related pathways are Hematopoietic Stem Cell Differentiation Pathways and Lineage-specific Markers and Innate Immune System. Gene Ontology (GO) annotations related to this gene include transmembrane signaling receptor activity. Learn more: cd79b marker.
At Creative Biolabs, total complement activity tests are respectively carried out by CH50 for the complement classical pathway, AH50 for the complement alternative pathway, and LP50 for the complement lectin pathway. Among the tests, CH50 and AH50 assays are based on the complement hemolytic activity detection while the LP50 is based on the enzyme immunoassay of the terminal complement complex detection. All test procedures are shown as follows, both a one-stop test for all three pathways and a test for any one pathway based on the client’s demands are all available. Learn more: hemolytic assay complement
Creative Biolabs has always been interested in the development of a novel drug delivery system, which aims to deliver the drug at a rate directed by the needs of the body during the period of treatment, and channel the active entity to the site of action. In recent years, vesicles have become the vehicle of choice in drug delivery. Having worked in the field of bioactives delivery for many years, Creative Biolabs has developed comprehensive sets of innovative and diversified drug delivery platforms based on vesicular system. At present, we are able to provide a full range of services and customized products concerning versatile carrier. Learn more: Vesicular system-based drug delivery.